https://www.livemint.com/ajanta-pharma/bonus/companyid-s0003497
Ajanta Pharma Bonus: Ajanta Pharma Bonus Shares, Bonus Issue, Upcoming Ajanta Pharma Bonus Shares
Ajanta Pharma Bonus: Find out Ajanta Pharma Bonus Shares and Upcoming Bonus Issues. Stay Informed and Maximize Your Investments with Our Trusted Platform. |...
ajanta pharmabonus sharesissueupcoming
https://www.livemint.com/ajanta-pharma/news/companyid-s0003497
Ajanta Pharma News: Find Ajanta Pharma News Today, Latest News Ajanta Pharma
Ajanta Pharma News: Get the latest Ajanta Pharma news today. Stay Informed with our up-to-date coverage of Ajanta Pharma's latest news and developments. Stay...
ajanta pharmanewsfindtodaylatest
https://www.livemint.com/market/market-stats/ajanta-pharma-q4-results-s0003497
Ajanta Pharma Q4 Results 2026 - Find Ajanta Pharma Q4 Earnings Result | AJANTPHARM Q4 results
AJANTPHARM Q4 Results: Check out Ajanta Pharma Q4 Result news, Ajanta Pharma Q4 Earnings result updates and highlights. | AJANTPHARM Q4 Results 2026
ajanta pharmaresults 2026q4findearnings
https://www.livemint.com/ajanta-pharma/board-meetings/companyid-s0003497
Ajanta Pharma Board Meetings | Board Meeting Dates of Ajanta Pharma
Ajanta Pharma Board Meetings: Stay updated with the Board Meetings of Ajanta Pharma. Access the latest Board Meeting Dates and valuable insights on Ajanta...
ajanta pharmaboard meetingsdates
https://ajantapharma.com.ph/
Ajanta | Ajanta Pharma Philippines
Aug 10, 2020 - VIEW ALL VIEW ALL VIEW ALL LATEST ARTICLES Hyperuricemia is a frequent complication of chronic kidney disease (CKD). Febuxostat is a novel xanthine oxidase...
ajanta pharmaphilippines
https://www.livemint.com/market/market-stats/ajanta-pharma-q1-results-s0003497
Ajanta Pharma Q1 Results 2026 - Find Ajanta Pharma Q1 Earnings Result | AJANTPHARM Q1 results
AJANTPHARM Q1 Results: Check out Ajanta Pharma Q1 Result news, Ajanta Pharma Q1 Earnings result updates and highlights. | AJANTPHARM Q1 Results 2026
ajanta pharmaq1 results2026findearnings
https://www.financialexpress.com/market/Ajanta-Pharma-Ltd-share-price/?ref=articlehyperlinking
Ajanta Pharma Share Price Today: Ajanta Pharma Stock Price Live NSE/BSE, Ajanta Pharma Share Price,...
Ajanta Pharma Share Price Today (16th May, 2026): Check Ajanta Pharma Stock Price live NSE/BSE on financialexpress.com. Get Ajanta Pharma today's stock price,...
ajanta pharmashare pricetodaystocklive
https://www.livemint.com/ajanta-pharma/cash-flow-annual/companyid-s0003497
Ajanta Pharma Cashflow: Cashflow, Cash Flow Annual Statement, Free Cash Flow
Ajanta Pharma Cashflow: Discover Ajanta Pharma cash flow statement and analyze its free cash flow. Gain valuable insights into Ajanta Pharma Annual cash flow...
ajanta pharmacash flowannual statementcashflowfree
https://www.livemint.com/ajanta-pharma/rights/companyid-s0003497
Ajanta Pharma Rights: Rights, Rights Issue, Rights History
Ajanta Pharma Rights: Explore the History and Updates of Ajanta Pharma Rights Issue. Stay Informed on Ajanta Pharma Rights and Access Valuable Insights into...
ajanta pharmarights issuehistory
https://www.livemint.com/ajanta-pharma/share-holdings/companyid-s0003497
Ajanta Pharma shareholdings: Find Ajanta Pharma Shareholding Pattern and Ownership
Ajanta Pharma shareholdings: Gain valuable insights into Ajanta Pharma shareholdings and ownership. Explore the shareholding pattern and information on Ajanta...
ajanta pharmashareholding patternshareholdingsfindownership
https://www.ndtvprofit.com/markets/ajanta-pharma-shares-hit-record-high-after-q1-profit-beats-estimates-10055846
Ajanta Pharma Shares Hit Record High After Q1 Profit Beats Estimates
The pharmaceutical company's first-quarter net profit rose 19% YoY to Rs 208 crore beating Bloomberg estimate of Rs 150 crore.
ajanta pharmahit recordshares
https://www.business-standard.com/markets/capital-market-news/ajanta-pharma-pat-jumps-56-yoy-to-rs-210-cr-in-q3-fy24-124020100549_1.html
Ajanta Pharma PAT jumps 56% YoY to Rs 210 cr in Q3 FY24 | Capital Market News - Business Standard
The pharma major's consolidated net profit jumped 56.14% to Rs 210.03 crore in Q3 FY24 as compared with Rs 134.51 crore posted in Q3 FY23.
https://www.business-standard.com/amp/markets/capital-market-news/ajanta-pharma-ltd-soars-1-25-up-for-fifth-straight-session-124112200543_1.html
Ajanta Pharma Ltd soars 1.25%, up for fifth straight session | Capital Market News - Business...
Ajanta Pharma Ltd is quoting at Rs 2982.3, up 1.25% on the day as on 12:44 IST on the NSE. The stock is up 52% in last one year as compared to a 19.56% spurt...
https://www.business-standard.com/article/markets/yes-bank-reliance-capital-tvs-motor-and-ajanta-pharma-top-stocks-to-watch-119043000112_1.html
YES Bank, Reliance Capital, TVS Motor and Ajanta Pharma top stocks to watch | News on Markets -...
Here's a look at the top stocks that may remain in focus today -
https://www.businesstoday.in/markets/stocks/story/stocks-in-news-ril-wipro-ajanta-pharma-kotak-mahindra-bank-and-more-372841-2023-03-10
Stocks in news: RIL, Wipro, Ajanta Pharma, Kotak Mahindra Bank and more - BusinessToday
Mar 10, 2023 - Stocks to watch out for today: RIL, Wipro, Ajanta Pharma, Poonawalla Fincorp, Home First Fin, Kotak Mahindra Bank and more
kotak mahindra bank
https://www.ndtvprofit.com/markets/healthcare-q4-results-preview-sun-pharma-cipla-dr-reddys-ajanta-pharma-orchid-pharma-rainbow-hospitals-in-focus-check-target-price-potential-upside-to-11358870
Healthcare Q4 Results Preview: Sun Pharma, Cipla, Dr. Reddy's, Ajanta Pharma, Orchid Pharma,...
The quarter is likely to reflect mixed implications from the US-Iran conflict, as higher freight and raw material costs could partially offset the favorable...
dr reddy sresults previewsun pharma
https://www.financialexpress.com/market/stocks-making-biggest-moves-midday-hindustan-copper-ola-electric-tata-capital-ajanta-pharma-and-more-4087071/
Stocks making biggest moves midday: Hindustan Copper, Ola Electric, Tata Capital, Ajanta Pharma and...
Hindustan Copper, Ola Electric, Tata Capital, Ajanta Pharma, and Oswal Pumps move sharply in a flat market; key triggers lift select stocks.
https://www.business-standard.com/amp/markets/capital-market-news/ajanta-pharma-consolidated-net-profit-rises-11-12-in-the-march-2025-quarter-125050200143_1.html
Ajanta Pharma consolidated net profit rises 11.12% in the March 2025 quarter | Capital Market News...
Sales rise 11.04% to Rs 1170.41 crore